Reckitt Benckiser Group plc (ETR:3RB)

Market Cap	37.19B
Revenue (ttm)	17.13B
Net Income (ttm)	1.72B
Shares Out	n/a
EPS (ttm)	2.46
PE Ratio	21.57
Forward PE	n/a
Dividend	2.36 (4.28%)
Ex-Dividend Date	Apr 10, 2025

Volume	4,242
Average Volume	9,295
Open	55.06
Previous Close	54.30
Day's Range	54.80 - 55.50
52-Week Range	47.52 - 64.86
Beta	0.17
RSI	36.64
Earnings Date	Jul 24, 2025

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol bran...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1819
• Employees: 37,900
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 3RB

Financial Performance

In 2024, Reckitt Benckiser Group's revenue was 14.17 billion, a decrease of -3.00% compared to the previous year's 14.61 billion. Earnings were 1.43 billion, a decrease of -13.21%.

Financial numbers in GBP